Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses - Wei, Yanzhang; Sticca, Robert; Holmes, Lillia; Burgin, Kelly; Li, Jinhua; Williamson, Jane; Evans, Lyndon; Smith, Samuel; Stephenson, Joseph; Wagner, Thomas (International journal of oncology, 2006)
Keywords: Adult; Aged; Biological and medical sciences; Cancer Vaccines - therapeutic use; CD4-Positive T-Lymphocytes - immunology; CD4-Positive T-Lymphocytes - metabolism; CD8-Positive T-Lymphocytes - immunology; CD8-Positive T-Lymphocytes - metabolism; Dendritic Cells - cytology; Dendritic Cells - immunology; Dermatology; Female; Flow Cytometry; Humans; Hybrid Cells - immunology; Hybrid Cells - transplantation; Immunotherapy, Adoptive - methods; Interferon-gamma - metabolism; Interleukin-2 - therapeutic use; Leukocytes, Mononuclear - immunology; Leukocytes, Mononuclear - pathology; Male; Medical sciences; Melanoma - immunology; Melanoma - pathology; Melanoma - therapy; Middle Aged; Neoplasm Metastasis; Pilot Projects; Skin Neoplasms - immunology; Skin Neoplasms - pathology; Skin Neoplasms - therapy; Treatment Outcome; Tumors; Tumors of the skin and soft tissue. Premalignant lesions; Human; clinical study; Dendritic cell; Low dose; Vaccination; Cytokine; melanoma; Malignant tumor; Metastasis; Prevention; fusion; Cancerology; Treatment; Interleukin 2; Antigen presenting cell; Immunotherapy; tumor; Malignant melanoma; Advanced stage; dendritoma